GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $731,000 | +7.3% | 6,335 | -9.5% | 0.08% | -32.5% |
| Q3 2020 | $681,000 | +55.5% | 6,998 | +67.0% | 0.12% | +172.1% |
| Q4 2019 | $438,000 | -0.7% | 4,191 | +9.2% | 0.04% | +26.5% |
| Q3 2019 | $441,000 | +32.8% | 3,838 | +99.3% | 0.03% | +78.9% |
| Q2 2019 | $332,000 | -55.0% | 1,926 | -74.6% | 0.02% | -52.5% |
| Q4 2018 | $738,000 | -3.0% | 7,574 | +71.9% | 0.04% | -14.9% |
| Q3 2018 | $761,000 | +265.9% | 4,405 | +194.8% | 0.05% | +422.2% |
| Q2 2018 | $208,000 | -90.1% | 1,494 | -90.6% | 0.01% | -91.9% |
| Q4 2017 | $2,098,000 | +14.5% | 15,893 | -12.0% | 0.11% | +22.0% |
| Q3 2017 | $1,832,000 | – | 18,052 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
| VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
| Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
| United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
| PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
| Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
| CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
| Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |